Oragenics, Inc. (OGEN)
USD 0.33
(-2.99%)
USD 0.33
(-2.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.29 Million | -15.22 Million | -13.47 Million | -16.95 Million | -13.01 Million | -9.07 Million |
| Net Income | -20.65 Million | -14.28 Million | -15.71 Million | -26.43 Million | -15.56 Million | -9.91 Million |
| Depreciation & Amortization | 27.39 Thousand | 44.66 Thousand | 41.23 Thousand | 51.7 Thousand | 62.62 Thousand | 30.11 Thousand |
| Deferred income taxes | -25.79 Thousand | - | -1.76 Million | -132.75 Thousand | - | - |
| Stock-based compensation | 1.01 Million | 742.2 Thousand | 1.68 Million | 1.49 Million | 552.99 Thousand | 1.02 Million |
| Change in working capital | 1.99 Million | -1.71 Million | 512.14 Thousand | 37.01 Thousand | 1.92 Million | -228.14 Thousand |
| Other non-cash items | 10.32 Million | -10.96 Thousand | 1.76 Million | 8.03 Million | 12 Thousand | 12 Thousand |
| Investing Cash Flow | -936.28 Thousand | -115.51 Thousand | -43.87 Thousand | - | -25.21 Thousand | -124.72 Thousand |
| Investments in PPE | - | -127.51 Thousand | -43.87 Thousand | - | -25.21 Thousand | -124.72 Thousand |
| Acquisitions | 63.71 Thousand | 12 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -936.28 Thousand | 12 Thousand | - | - | - | - |
| Financing Cash Flow | 283.88 Thousand | -494.91 Thousand | 23.14 Million | 16.32 Million | 11.09 Million | 23.24 Million |
| Debt repayment | -566.04 Thousand | -564.2 Thousand | -524.98 Thousand | -197.33 Thousand | -252.92 Thousand | -200.75 Thousand |
| Dividends payments | - | - | -1.11 Million | -661.45 Thousand | -413.21 Thousand | -58.67 Thousand |
| Common Stock Repurchased | - | - | -5.63 Million | - | - | - |
| Common Stock Issuance | 849.92 Thousand | 69.28 Thousand | 29.3 Million | 16.52 Million | 11.35 Million | 23.44 Million |
| Other Financing Activities | 283.88 Thousand | -494.91 Thousand | 23.14 Million | 16.32 Million | 11.09 Million | 23.24 Million |
| Accounts receivables | - | 6987.00 | -6987.00 | - | - | - |
| Accounts payables | 25.79 Thousand | 176.62 Thousand | 10.55 Thousand | -603.73 Thousand | 498.05 Thousand | 225.31 Thousand |
| Inventory | - | -6987.00 | 6987.00 | - | - | - |
| Other working capital | 1.99 Million | -1.89 Million | 501.58 Thousand | 640.74 Thousand | 1.42 Million | -453.45 Thousand |
| Cash at beginning of period | 11.42 Million | 27.26 Million | 17.63 Million | 18.26 Million | 20.2 Million | 6.16 Million |
| Cash at end of period | 3.48 Million | 11.42 Million | 27.26 Million | 17.63 Million | 18.26 Million | 20.2 Million |
| Capital Expenditure | - | -127.51 Thousand | -43.87 Thousand | - | -25.21 Thousand | -124.72 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.94 Million | -15.83 Million | 9.62 Million | -628.41 Thousand | -1.94 Million | 14.04 Million |
| Free Cash Flow | -7.29 Million | -15.35 Million | -13.51 Million | -16.95 Million | -13.03 Million | -9.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.3 Million | -2.45 Million | -12.74 Million | -20.65 Million | -2.01 Million | -3.05 Million |
| Depreciation & Amortization | - | - | - | 27.39 Thousand | 4785.00 | 11.3 Thousand |
| Deferred income taxes | - | - | 476.03 Thousand | -25.79 Thousand | - | -719.77 Thousand |
| Stock-based compensation | 58.22 Thousand | 69.34 Thousand | 470.3 Thousand | 1.01 Million | 402.92 Thousand | 63.62 Thousand |
| Change in working capital | 702.34 Thousand | -682.76 Thousand | 848.67 Thousand | 2.01 Million | 124.6 Thousand | 399.02 Thousand |
| Other non-cash items | -543.24 Thousand | 763.16 Thousand | 10.16 Million | 11.34 Million | -22.44 Thousand | 719.77 Thousand |
| Investing Cash Flow | - | - | -999.99 Thousand | -936.28 Thousand | 63.71 Thousand | - |
| Investments in PPE | -1.00 | - | - | - | - | - |
| Acquisitions | - | - | 1.00 | 63.71 Thousand | 63.71 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -1 Million | -1 Million | 1.00 | - |
| Financing Cash Flow | 821.16 Thousand | 1.65 Million | -180.59 Thousand | 283.88 Thousand | 732.11 Thousand | -107.89 Thousand |
| Debt repayment | -126.84 Thousand | -185.86 Thousand | -180.71 Thousand | -566.04 Thousand | -117.68 Thousand | -107.89 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 948 Thousand | 1.83 Million | 118.00 | 849.92 Thousand | 849.8 Thousand | - |
| Other Financing Activities | 821.16 Thousand | -185.86 Thousand | -180.59 Thousand | 283.88 Thousand | 732.11 Thousand | -107.89 Thousand |
| Accounts receivables | - | - | 35.1 Thousand | - | -21.94 Thousand | -13.16 Thousand |
| Accounts payables | 601.46 Thousand | -693.82 Thousand | 598.19 Thousand | 25.79 Thousand | -298.32 Thousand | -620.37 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 100.87 Thousand | 11.06 Thousand | 215.37 Thousand | 1.99 Million | 444.87 Thousand | 1.03 Million |
| Cash at beginning of period | 2.07 Million | 3.48 Million | 5.76 Million | 11.42 Million | 6.47 Million | 9.15 Million |
| Cash at end of period | 1.34 Million | 2.07 Million | 3.48 Million | 3.48 Million | 5.76 Million | 6.47 Million |
| Capital Expenditure | -1.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -723.36 Thousand | -1.41 Million | -2.28 Million | -7.94 Million | -707.17 Thousand | -2.68 Million |
| Free Cash Flow | -1.54 Million | -3.06 Million | -1.1 Million | -7.29 Million | -1.5 Million | -2.57 Million |
PSHZF
0H7R
SIYSIL
BVVBY
MONDY
TEXRAIL